Skip to main content
. 2022 Feb 2;12:7. doi: 10.1186/s13550-022-00880-4

Table 2.

Raw baseline toxicity prior to PRRT and at screening (i.e. prior to [166Ho]-radioembolization)

CTCAE grade
Pre-PRRT Baseline
1–2 3 4 1–2 3 4
Thrombocyte 3/30 12/31
Neutrophil 2/26 1/31
Lymphocyte 1/27 11/31 7/31
Leukocyte 3/30 11/31
Hemoglobin 13/30 17/31

Values are n/available observed patients with the designated toxicity grade